Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study. - Wikidata - wikimedia - TriplyDB

Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study.

Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study.

http://www.wikidata.org/entity/Q33737093

about

Fluid Biomarkers in Clinical Trials of Alzheimer's Disease Therapeutics The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy.Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin Diagnostic value of blood thiamine metabolites in Alzheimer's disease examined by 11C-PiB PET scanning Non-invasive screening for Alzheimer's disease by sensing salivary sugar using Drosophila cells expressing gustatory receptor (Gr5a) immobilized on an extended gate ion-sensitive field-effect transistor (EG-ISFET) biosensor.Salivary tau species are potential biomarkers of Alzheimer's disease.Mass Spectrometry-based Proteomics and Peptidomics for Systems Biology and Biomarker Discovery.Can Salivary Acetylcholinesterase be a Diagnostic Biomarker for Alzheimer?Proteomic analysis of saliva in HIV-positive heroin addicts reveals proteins correlated with cognition.Fish-on-a-chip: a sensitive detection microfluidic system for Alzheimer's disease.Targeting microglia for the treatment of Alzheimer's disease.Salivary proteomics and biomarkers in neurology and psychiatry.Amyloid-β as a biomarker for Alzheimer's disease: quantification methods in body fluids.A Method for Diagnosing Alzheimer's Disease Based on Salivary Amyloid-β Protein 42 Levels.Potential peripheral biomarkers for the diagnosis of Alzheimer's disease.Amyloidogenic amyloid-β-peptide variants induce microbial agglutination and exert antimicrobial activity.Dynamic changes of oligomeric amyloid β levels in plasma induced by spiked synthetic Aβ42 Antioxidant Defence, Oxidative Stress and Oxidative Damage in Saliva, Plasma and Erythrocytes of Dementia Patients. Can Salivary AGE be a Marker of Dementia?A quantum dot probe conjugated with aβ antibody for molecular imaging of Alzheimer's disease in a mouse model.Lacrimal gland uptake on F-18 florbetapir amyloid positron emission tomography scan.Ultra-sensitive detection of protein biomarkers for diagnosis of Alzheimer's disease Salivary beta amyloid protein levels are detectable and differentiate patients with Alzheimer's disease dementia from normal controls: preliminary findings

P2860

Q26784569-C65EE447-B5EE-488D-BA6B-D38F0183D3CD Q30668465-67E17E0D-1603-4452-8213-3AC68DBF045E Q33797110-2DA268B5-8E11-41B6-8DF1-C11E432775A1 Q33827082-7489D522-D4AB-4A8B-AA76-53650F319BA6 Q35123008-5DF88519-623D-4FCB-923D-C617C309A4EE Q35826368-F205097A-BDAB-421C-8814-5C6CE0822B93 Q37552845-F9E6C890-E539-4564-BE96-8634291F9B57 Q37663763-B39D4F30-C5F0-4E80-9BB4-C0003B0E834E Q37694708-8113021A-5AA5-4297-A9E1-C34D35503974 Q37880972-89101F28-2DC5-45D9-92D9-57FAA4976FFA Q38272915-672ABA05-EFE2-48C9-B3DE-48711E496785 Q38335930-03A57077-FE59-4BE6-A792-C22C0E695AC5 Q38543843-24FE6687-F0F8-49C3-9051-8617E021E1B4 Q38803093-1F79D04B-5310-4BE2-BE3C-DA9F2BC50F4C Q38833738-A885D8A6-E40D-48E6-9B53-234E31BEF0CE Q39394951-D9127456-112D-4A77-9E33-AA5D04E6670F Q42682593-6CA3B5DF-5C65-4A08-81C1-3A6586AEDD39 Q47120247-647158F7-577D-43EF-B037-B883B8448F40 Q50972636-0D1EBC4B-60FD-4C23-A3F8-6256B8F5430C Q52682289-02534812-37EE-429A-AABC-D2418D5EB7D2 Q58376432-2F313DF2-D6D4-482D-9534-6C5A918E6DF3 Q58694906-8F01D5D0-F90C-46A7-A911-FF4301CAFA75

P2860

Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study.

http://www.wikidata.org/entity/Q33737093

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study.

@ast

Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study.

@en

type

label

Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study.

@ast

Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study.

@en

prefLabel

Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study.

@ast

Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study.

@en

P1433

Q33737093-6F1208DE-0F06-4643-A627-194EFD3624FD

P1476

Q33737093-4BD9DE81-83E3-4872-B3CC-E19C9E41138D

P2093

Q33737093-01F92868-D4FC-4C97-A34E-ADE4C0AD6BC4

Q33737093-6F7B2846-4EC1-4B56-A2BA-30444FD864F2

Q33737093-903EE693-1463-483F-B029-579694DB1799

P2860

Q33737093-00F4354C-0255-4E41-B292-A1080202F29A

Q33737093-0B9D7B52-F9F3-426F-9E9C-220CB9070DAB

Q33737093-0C7C154F-F2D7-41D1-84E8-278F7A950E8D

Q33737093-1342BE86-6374-4B5F-AEEB-6D29FA6481FE

Q33737093-15B9D892-9EB6-4EEB-B6E3-791BE5E0A0C0

Q33737093-1C5B8C9A-7389-435C-843B-5F59EC9092CA

Q33737093-22868DEC-6B86-483E-88B2-15777A523841

Q33737093-24F563BF-46CA-4DFF-B022-7921753FC969

Q33737093-259E60AC-7285-4C2D-B466-33581D3C9595

Q33737093-26B3E158-AFA2-4DDE-8A40-9B0224A594A5

P2888

Q33737093-854739E3-D6F2-44C7-9F65-09B7A9E86105

P304

Q33737093-FD83CDA4-0FAD-4BA9-B530-22F6780702A4

P31

Q33737093-0EE1579B-A3E3-404B-A244-2F7298EEE7CC

P356

Q33737093-33CE25F9-1FB3-42B7-AEBC-4ED664DEA748

P478

Q33737093-9D10D0AF-2B00-4226-BE54-C3C5EE9067FA

P50

Q33737093-59EB4B2D-BB64-474F-86D1-7D18F7AA049A

Q33737093-67D79F2C-D228-483D-989F-08A4CFFA95B8

P577

Q33737093-AD6CE12F-9684-4180-AC21-EAFCFD1A2DFA

P5875

Q33737093-42B76FFF-B51B-4B01-80F7-B41B22C1C8BB

P6179

Q33737093-641B462F-1210-4F00-B3C7-F1C4D44FB445

P698

Q33737093-9EEA5E80-C43A-41B0-BD12-DFE69933CB56

P921

Q33737093-190C603D-495E-4074-887C-8AEFBD835598

Q33737093-BC2A6D07-952D-4A3D-A57A-51E41F868A07

P932

Q33737093-D75A385E-0904-4709-BDEF-F71D578EACA7

P356

1471-2377-10-108

P1433

P1476

Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study

@en

P2093

Desiree Antequera

http://www.w3.org/2001/XMLSchema#string

Felix Bermejo-Pareja

http://www.w3.org/2001/XMLSchema#string

Jose A Molina

http://www.w3.org/2001/XMLSchema#string

P2860

Plasma and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated actin-binding domain

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Tissue kallikrein mK13 is a candidate processing enzyme for the precursor of interleukin-1beta in the submandibular gland of mice

Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease.

Choroid plexus: target for polypeptides and site of their synthesis.

Diagnostic criteria for Parkinson disease.

CSF markers for incipient Alzheimer's disease.

Criteria for diagnosing Parkinson's disease.

P2888

1471-2377-10-108

P304

108

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2377-10-108

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47675219

http://www.w3.org/2001/XMLSchema#string

P6179

1026947302

http://www.w3.org/2001/XMLSchema#string

P698

21047401

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2987856

http://www.w3.org/2001/XMLSchema#string